{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:10:19Z","timestamp":1780337419107,"version":"3.54.1"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Objective: This study aimed to investigate the impact of elevated CRP on survival outcomes in small renal masses (SRM). Methods: This was a multi-institutional retrospective analysis of SRM (\u22643 cm) managed surgically. The cohort was divided into elevated CRP (\u22650.5 mg\/dL) vs. non-elevated CRP groups (&lt;0.5). The primary outcome was all-cause mortality (ACM). The secondary outcomes were non-cancer (NCM) and cancer-specific mortality (CSM). Cox-regression analysis was used to elucidate predictive factors for mortality outcomes. Kaplan\u2013Meier Analysis (KMA) was performed to analyze 10-year overall (OS), cancer-specific (CSS) and non-cancer-specific survival (NCS). Results: A total of 1001 patients were analyzed (309 non-elevated CRP\/692 elevated CRP; median follow-up 70 months). Elevated CRP was an independent predictor for ACM (HR = 2.60, p &lt; 0.001) NCM (HR = 2.90, p = 0.002), and CSM (HR = 1.20, p = 0.011). KMA comparing elevated vs. non-elevated groups revealed greater 10-year OS (p &lt; 0.001) and NCS (p &lt; 0.001) for non-elevated CRP, but no significant difference in 10-year CSS (p = 0.295). A total of 83 deaths were observed in elevated CRP (71 NCM\/12 CSM\u2014all clear-cell histology). The sensitivity\/specificity of elevated CRP was 0.87\/0.33, 0.75\/0.81, and 0.90\/0.33 for ACM, CSM, and NCM. By utilizing CRP for a decision-making algorithm prioritizing biopsy in CRP elevation and offering surveillance in benign or indolent histology, surgery may be avoided in 218 patients, in whom there were 38 fatalities, all NCM. Conclusions: Elevated CRP was an independent predictor of survival outcomes in SRM \u2264 3 cm. From a competing mortality standpoint, patients with elevated CRP had significantly worsened NCM compared to CSM. In such patients, upfront oncologic risk stratification through biopsy may be considered, and indolent\/low-grade neoplasms should be strongly considered for non-surgical management.<\/jats:p>","DOI":"10.3390\/curroncol33060327","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:11:01Z","timestamp":1780333861000},"page":"327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis"],"prefix":"10.3390","volume":"33","author":[{"given":"Margaret F.","family":"Meagher","sequence":"first","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Birouty","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Musso","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Puri","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-3051","authenticated-orcid":false,"given":"Aaron","family":"Ahdoot","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Dabbas","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Cortes","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Master","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Liss","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-0711","authenticated-orcid":false,"given":"Ithaar H.","family":"Derweesh","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13244-020-00853-y","article-title":"Active surveillance of small renal masses","volume":"11","author":"Corominas","year":"2020","journal-title":"Insights Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","article-title":"Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Finelli","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2023.07.005","article-title":"Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?","volume":"85","author":"Wang","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00345-010-0516-8","article-title":"Management of small renal masses: A review","volume":"28","author":"Remzi","year":"2010","journal-title":"World J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.clgc.2021.02.003","article-title":"Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)","volume":"19","author":"Patel","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.3399\/bjgp13X669185","article-title":"Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions","volume":"63","author":"Oppong","year":"2013","journal-title":"Br. J. Gen. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.52733\/KCJ23n3-or1","article-title":"Urine C-reactive protein content and non-invasive molecular grading of renal cell carcinoma","volume":"23","author":"Morrissey","year":"2025","journal-title":"Kidney Cancer J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/ijc.32650","article-title":"Searching for prognostic biomarkers for small renal masses in the urinary proteome","volume":"146","author":"Batruch","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bju.15200","article-title":"Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: Analysis from the INternational Marker Consortium for Renal Cancer (INMARC)","volume":"127","author":"Cotta","year":"2021","journal-title":"BJU Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0974-7796.106959","article-title":"Assessment of Clavien-Dindo classification in patients >75 years undergoing nephrectomy\/nephroureterectomy","volume":"5","author":"Khan","year":"2013","journal-title":"Urol. Ann."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00345-016-1911-6","article-title":"Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation","volume":"35","author":"Beksac","year":"2017","journal-title":"World J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ncpuro0254","article-title":"The natural history of small renal masses","volume":"2","author":"Volpe","year":"2005","journal-title":"Nat. Rev. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Steffens, S., K\u00f6hler, A., Rudolph, R., Eggers, H., Seidel, C., Janssen, M., Wegener, G., Schrader, M., and Kuczyk, M.A. (2012). Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-399"},{"key":"ref_16","first-page":"E348","article-title":"Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)","volume":"111","author":"Klatte","year":"2013","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1002\/cam4.5330","article-title":"Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years\u2019 experience at a regional cancer Centre","volume":"12","author":"Stares","year":"2023","journal-title":"Cancer Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14737140.2019.1571915","article-title":"Percutaneous renal mass biopsy: Historical perspective, current status, and future considerations","volume":"19","author":"Cotta","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clgc.2023.10.012","article-title":"Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal","volume":"22","author":"Staehler","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ucl.2023.01.002","article-title":"The Changing Role of Renal Mass Biopsy","volume":"50","author":"Ali","year":"2023","journal-title":"Urol. Clin."},{"key":"ref_21","unstructured":"(2024, April 16). EAU Guidelines on RCC\u2014Diagnostic Evaluation. Uroweb\u2014European Association of Urology. Available online: https:\/\/uroweb.org\/guidelines\/renal-cell-carcinoma\/chapter\/diagnostic-evaluation."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15586\/jkcvhl.v10i1.259","article-title":"The Significance of Serum C-Reactive Protein and Neutrophil\u2013Lymphocyte Ratio in Predicting the Diagnostic Outcomes of Renal Mass Biopsy Procedure","volume":"10","author":"Colakerol","year":"2023","journal-title":"J. Kidney Cancer VHL"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.juro.2012.09.032","article-title":"Accuracy of Determining Small Renal Mass Management with Risk Stratified Biopsies: Confirmation by Final Pathology","volume":"189","author":"Halverson","year":"2013","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.juro.2014.06.028","article-title":"Evaluation of Renal Mass Biopsy Risk Stratification Algorithm for Robotic Partial Nephrectomy\u2014Could a Biopsy Have Guided Management?","volume":"192","author":"Rahbar","year":"2014","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.juro.2011.09.055","article-title":"The Cost-Effectiveness of Immediate Treatment, Percutaneous Biopsy and Active Surveillance for the Diagnosis of the Small Solid Renal Mass: Evidence From a Markov Model","volume":"187","author":"Heilbrun","year":"2012","journal-title":"J. Urol."},{"key":"ref_26","first-page":"790.e9","article-title":"Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses","volume":"39","author":"Srivastava","year":"2021","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2015.07.072","article-title":"Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy","volume":"69","author":"Marconi","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_28","first-page":"496","article-title":"Committee for Establishment of the Clinical Practice Guideline for the Management of Renal Cell Carcinoma and the Japanese Urological Association. Evidence-based clinical practice guideline for renal cell carcinoma: The Japanese Urological Association 2011 update","volume":"19","author":"Fujioka","year":"2012","journal-title":"Int. J. Urol. Off. J. Jpn. Urol. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12325-015-0180-x","article-title":"Cost-Effectiveness of Point-of-Care C-Reactive Protein Tests for Respiratory Tract Infection in Primary Care in England","volume":"32","author":"Hunter","year":"2015","journal-title":"Adv. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1803185","article-title":"C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations","volume":"381","author":"Butler","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/6\/327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:42:51Z","timestamp":1780335771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/6\/327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["curroncol33060327"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33060327","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}